Kidney cancer trials in Poland

In Poland 12 Also abroad 485

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Where
Cracow, Gliwice, Siedlce, Skorzewo, Warsaw
Age
18 years and over
People
758 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00
Phase 3Taking people
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Bielsko-Biala, Cracow, Koszalin, Otwock, Poznan, Rzeszow, Siedlce, Skorzewo, Tomaszow Mazowiecki, Warsaw, Wroclaw
Age
18 years and over
People
720 worldwide
Run by
Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00
Phase 1/2Taking people
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Where
Bydgoszcz, Gdansk, Warsaw
Age
18 years to 120 years
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Bydgoszcz, Warsaw
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 3Taking people
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Where
Bydgoszcz, Cracow, Koszalin, Przemyśl, Siedlce, Skorzewo, Warsaw
Age
18 years and over
People
904 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00
Phase 1Taking people
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
Where
Bydgoszcz, Otwock, Warsaw
Age
18 years and over
People
40
Run by
Molecure S.A.
See details and how to joinNCT05759923 · EU 2024-510836-31-00
No phaseTaking people
Occupational Situation and Return to Work of Urological Patients
Where
Krakow
Age
18 years and over
People
2,000
Run by
Jagiellonian University
See details and how to joinNCT07088536
Phase 1Taking people
An open-label, multicentre, rollover study to evaluate safety and antineoplastic activity of OATD-02 in patients with selected advances and/or metastatic solid tumours who completed the first-in-human study OATD-02-C-01
Where
Bydgoszcz, Otwock, Warsaw
Age
18 years and over
People
30
Run by
Molecure S.A.
See details and how to join2024-513006-61-00 · EU 2024-513006-61-00
Phase 3Taking people
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Where
Brzozów, Gdynia, Krakow, Poznan
Age
18 years and over
People
413 worldwide
Run by
Xynomic Pharmaceuticals, Inc.
See details and how to joinNCT03592472
No phaseTaking people
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Where
Gdansk, Warsaw
Age
18 years and over
People
200 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767
No phaseTaking people
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
Where
Otwock, Warsaw
Age
18 years and over
People
10,000 worldwide
Run by
Azienda Ospedaliero-Universitaria Careggi
See details and how to joinNCT05363657